COMPANY INFO
Hyro's actual company name is HYRO AI INC., founded in 2014 by Israel Krush and Rom Cohen. It is a New York City-based software development company with approximately 107 employees, operating in the AI-based conversational platform industry. Hyro provides an AI-driven platform that automates tasks such as patient record identification, scheduling management, and prescription support, leveraging advanced APIs to streamline healthcare communications. Its website is https://hyro.ai.
Hyro AI Inc. is a software development company founded in 2014 by Israel Krush and Rom Cohen. Based in New York City with global presence including an R&D center in Tel Aviv, Hyro operates within the AI-based conversational platform industry, employing approximately 107 people. The company specializes in automating workflows for healthcare organizations, offering an advanced AI-driven platform that streamlines patient record identification, scheduling management, and prescription support by leveraging sophisticated APIs to enhance healthcare communication.
Hyro AI Inc. funding history demonstrates a strong upward trajectory, with approximately $50 million raised across five rounds. The company has strategically targeted key milestones, starting with initial product development through seed capital and moving onto expansion and commercialization in later rounds. Notable investors from both the healthcare and technology sectors have participated, reflecting confidence in Hyro’s venture capital-backed model. The company's funding approach has enabled the expansion of its conversational AI solutions into regulated industries beyond healthcare, such as insurance and banking, supporting platform innovation, talent acquisition, and broadening partnerships.
This most recent Series B round enables Hyro AI Inc. to accelerate the development of responsible AI-powered communications for enterprise clients. The funds are earmarked for expanding into regulated sectors like insurance and banking, recruiting specialized talent, and strengthening the capabilities and partnerships of its conversational AI platform.
The Series A round was led by Spero Ventures and included participation from Mindset Ventures, Twilio, and existing backers. The funding was allocated to advancing Hyro’s adaptive communications platform, supporting product innovation, and driving customer growth in the healthcare industry.
Hyro secured Seed funding to support the launch and initial development of its AI-powered conversational platform, with a focus on revolutionizing workflow automation for the healthcare sector.
Macquarie Group is a global financial services firm that participated prominently in Hyro AI Inc.’s Series B round, helping propel the company’s expansion into new markets and supporting large-scale enterprise adoption.
Spider Capital is an early-stage venture capital firm with expertise in SaaS and enterprise technologies. As an early backer, Spider Capital has supported Hyro’s initial development and ongoing growth.
Hanaco Ventures is a venture capital fund investing in early to growth-stage technology companies. Hanaco has participated in multiple rounds for Hyro AI Inc., providing both capital and operational guidance.
K20 Fund is a venture capital fund focused on scaling next-generation tech companies. The fund is a key investor in Hyro’s later-stage funding, contributing to the company’s footprint in AI-powered enterprise solutions.
Healthier Capital leads investments in innovative health tech startups. They led Hyro's 2024 Series B extension round, supporting expansion and responsible growth in healthcare AI.
Spero Ventures, leading the Series A round, is known for backing mission-driven technology companies improving lives. Spero's backing enabled Hyro to scale its adaptive conversational platform.
Mindset Ventures invests in enterprise technology and health tech. Their investment in Hyro AI Inc. fostered product development and supported the company's U.S. and global market ambitions.
Twilio, a leader in communications APIs, joined Hyro’s Series A as a strategic investor, supporting integrations that amplify Hyro’s platform communication capabilities.
Black Opal Ventures backs transformative technologies in healthcare, joining the Series B to help accelerate Hyro’s mission to transform enterprise communication.
Liberty Mutual Strategic Ventures invests in cutting-edge tech impacting insurance and financial services, supporting Hyro AI Inc.’s push into regulated industries during the latest funding round.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Hyro AI Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.